EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

PARP inhibitors in breast cancer: From DNA repair targeting to next-generation precision therapeutics

Jesús Yaringaño, Isabel Pimentel, Thibault Thomas-Bonafos, Mafalda Oliveira, Cristina Saura, Kaïssa Ouali, Thomas Grinda, Elie Rassy, Barbara Pistilli, Judith Balmaña, Joana M Ribeiro

Cancer Treatment Reviews · 2026-12 · 151 · 103242

DOI: 10.1016/j.ctrv.2026.103242 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-12. Verfasst von Jesús Yaringaño und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Breast Cancer Group, Vall …. Die Arbeit nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: BCRF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BiomarkersBreast cancerCombination strategiesHomologous recombination deficiencyPARP inhibitorsPARP selectivity

Autor:innen und Institutionen

  • Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Hereditary Ca…
  • Department of Medical Oncology, Institute Gustave Roussy, Villejuif, France; Drug Development Department, Institute Gustave Roussy, Villejuif, France.
  • Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Department of Medical Oncology, Institute Gustave Roussy, Villejuif, France; Breast Cancer Group, Institute Gustave Roussy, Villejuif, France.

Förderung

  • BCRF

Zitieren

APA

Yaringaño, J., Pimentel, I., Thomas-Bonafos, T., Oliveira, M., Saura, C., Ouali, K., Grinda, T., Rassy, E., Pistilli, B., Balmaña, J., & Ribeiro, J. M. (2026). PARP inhibitors in breast cancer: From DNA repair targeting to next-generation precision therapeutics. Cancer Treatment Reviews, 151, 103242. https://doi.org/10.1016/j.ctrv.2026.103242

Vancouver

Yaringaño J, Pimentel I, Thomas-Bonafos T, Oliveira M, Saura C, Ouali K, et al. PARP inhibitors in breast cancer: From DNA repair targeting to next-generation precision therapeutics. Cancer Treatment Reviews. 2026;151:103242. doi:10.1016/j.ctrv.2026.103242

BibTeX
@article{Yaringao2026,
  author = {Yaringaño, Jesús and Pimentel, Isabel and Thomas-Bonafos, Thibault and Oliveira, Mafalda and Saura, Cristina and Ouali, Kaïssa and Grinda, Thomas and Rassy, Elie and Pistilli, Barbara and Balmaña, Judith and Ribeiro, Joana M},
  title = {PARP inhibitors in breast cancer: From DNA repair targeting to next-generation precision therapeutics},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  volume = {151},
  pages = {103242},
  doi = {10.1016/j.ctrv.2026.103242}
}
Kostenlos starten →